NYSE:CI - New York Stock Exchange, Inc. - US1255231003 - Common Stock - Currency: USD
THE CIGNA GROUP
NYSE:CI (1/27/2025, 11:48:07 AM)
300.23
+6.59 (+2.24%)
The current stock price of CI is 300.23 USD. In the past month the price increased by 4.26%. In the past year, price decreased by -1.4%.
As the US market prepares to open on Thursday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.
This year's JPMorgan health-care conference took place a month after UnitedHealthcare CEO Brian Thompson was fatally shot in New York City.
Many stocks flashed buy signals as the major indexes rose to or above key levels.
On Thursday, UnitedHealth Group (NYSE:UNH) reported the fourth-quarter 2024 earnings and reaffirmed 2025 guidance. The company reported adjusted EPS of $6.81, up from $6.16 a year ago, beating the consensus of $6.72. Revenues increased 6.8% year over year to $100.8 billion, missing the consensus of $101.76 billion. Fourth-quarter adjusted earnings from operations of $8.3 billion exclude the cyberattack direct response costs and South American impacts. The full-year medical care ratio was 85.5% c
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CVS | CVS HEALTH CORP | 8.76 | 70.03B | ||
LH | LABCORP HOLDINGS INC | 17.31 | 20.87B | ||
DGX | QUEST DIAGNOSTICS INC | 18 | 17.76B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 14.56 | 14.44B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 173.87 | 14.23B | ||
DVA | DAVITA INC | 19.14 | 13.94B | ||
CHE | CHEMED CORP | 24.84 | 8.52B | ||
HIMS | HIMS & HERS HEALTH INC | 70.68 | 6.79B | ||
CRVL | CORVEL CORP | 24.56 | 5.94B | ||
GH | GUARDANT HEALTH INC | N/A | 5.83B | ||
OPCH | OPTION CARE HEALTH INC | 26.24 | 5.31B | ||
RDNT | RADNET INC | 113.48 | 4.70B |
The Cigna Group is a global health company, which engages in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 72,500 full-time employees. The firm has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.
THE CIGNA GROUP
900 Cottage Grove Road
Bloomfield CONNECTICUT 06002 US
CEO: David M. Cordani
Employees: 71413
Company Website: https://www.thecignagroup.com/
Investor Relations: https://investors.thecignagroup.com/
Phone: 18602266000
The current stock price of CI is 300.23 USD.
The exchange symbol of THE CIGNA GROUP is CI and it is listed on the New York Stock Exchange, Inc. exchange.
CI stock is listed on the New York Stock Exchange, Inc. exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for CI, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of CI.
CI has a dividend yield of 1.9%. The yearly dividend amount is currently 4.9.
CI will report earnings on 2025-01-30, before the market open.
The PE ratio for CI is 10.92. This is based on the reported non-GAAP earnings per share of 27.49 and the current share price of 300.23 USD.
The outstanding short interest for CI is 1.77% of its float.
ChartMill assigns a technical rating of 1 / 10 to CI. When comparing the yearly performance of all stocks, CI is a bad performer in the overall market: 72.61% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to CI. Both the profitability and the financial health of CI get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months CI reported a non-GAAP Earnings per Share(EPS) of 27.49. The EPS increased by 18.13% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.31% | ||
ROA | 1.93% | ||
ROE | 7.22% | ||
Debt/Equity | 0.76 |
ChartMill assigns a Buy % Consensus number of 83% to CI. The Buy consensus is the average rating of analysts ratings from 34 analysts.
For the next year, analysts expect an EPS growth of 16.99% and a revenue growth 26.06% for CI